{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:15:45Z","timestamp":1790000145289,"version":"4.0.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2014.11.061","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:01:01Z","timestamp":1429747261000},"page":"A240-A247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S1","title":["Estimating costs of care for meningitis infections in low- and middle-income countries"],"prefix":"10.1016","volume":"33","author":[{"given":"Allison","family":"Portnoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Blommaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Hutubessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.11.061_bib0005","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0010","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0015","series-title":"Principles and considerations for adding a vaccine to a national immunization programme","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0020","unstructured":"International Monetary Fund (IMF) World Economic Outlook Database. [Online] Accessed 21 January 2014. Washington, DC: International Monetary Fund (IMF); 2013. Available at: http:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2013\/01\/weodata\/download.aspx"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7547-7-3","article-title":"The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis","volume":"7","author":"Ayieko","year":"2009","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0035","doi-asserted-by":"crossref","first-page":"e1001316","DOI":"10.1371\/journal.pmed.1001316","article-title":"Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis","volume":"9","author":"Rajasingham","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10729-010-9142-7","article-title":"Controlling for quality in the hospital cost function","volume":"14","author":"Carey","year":"2011","journal-title":"Health Care Manag Sci"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-6296(86)90001-9","article-title":"Estimating hospital costs","volume":"5","author":"Granneman","year":"1986","journal-title":"J Health Econ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/oxfordjournals.pubmed.a024587","article-title":"Issues in cost function specification for neonatal care: the Fordham case","volume":"19","author":"O\u2019Neill","year":"1997","journal-title":"J Public Health Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7547-6-22","article-title":"Capacity utilization and the cost of primary care visits: implications for the costs of scaling up health interventions","volume":"6","author":"Adam","year":"2008","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0060","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.socscimed.2006.04.023","article-title":"Determinants of variation in the cost of inpatient stays versus outpatient visits in hospitals: a multi-country analysis","volume":"63","author":"Adam","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7547-1-3","article-title":"Econometric estimation of country-specific hospital costs","volume":"1","author":"Adam","year":"2003","journal-title":"Cost Effectiveness Resour Allocation"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0070","series-title":"Development data and statistics 2011","author":"World Bank","year":"2013"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0075","series-title":"Development data and statistics 2010","author":"World Bank","year":"2013"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0080","series-title":"World Health Statistics 2012 (2010 Statistics)","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0085","series-title":"World Health Statistics 2012 (2009 Statistics)","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0090","first-page":"913","article-title":"Power function of the F-test under non-normal situations","volume":"66","author":"Tiku","year":"1971","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0100","series-title":"An introduction to the Bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/01621459.1983.10478017","article-title":"Smearing estimate: a nonparametric retransformation method","volume":"78","author":"Duan","year":"1983","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0110","first-page":"248","article-title":"The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia","volume":"20","author":"Alvis Guzm\u00e1n","year":"2006","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7705\/biomedica.v26i1.1396","article-title":"Extrapulmonary tuberculosis: a review of 102 cases in Pereira, Colombia","volume":"26","author":"Arciniegas","year":"2006","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1590\/S0124-00642007000300003","article-title":"Economic impact of pneumococcal vaccine on oncological patients","volume":"9","author":"Chica\u00edza-Becerra","year":"2007","journal-title":"Rev Salud Publica"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0125","first-page":"92","article-title":"Cost-effectiveness of universal pneumococcal vaccination in Uruguay","volume":"28","author":"Larraz","year":"2010","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0130","series-title":"An\u00e1lise e determina\u00e7\u00e3o de custos espec\u00edficos e consequ\u00eancias econ\u00f4mico-sociais na incorpora\u00e7\u00e3o da vacina contra meningite e doen\u00e7a meningoc\u00f3cica C conjugada na rotina do Programa Nacional de Imuniza\u00e7\u00f5es\/PNI","author":"Itria","year":"2011"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1590\/S0102-311X2012000400013","article-title":"Hospital costs related to streptococcal meningitis among children in Sao Jose dos Campos, Sao Paulo State, Brazil","volume":"28","author":"Lucarevschi","year":"2012","journal-title":"Cad Sa\u00fade P\u00fablica (Rio de Janeiro)"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0140","first-page":"14","article-title":"Epidemiology of Haemophilus influenzae b meningitis in Tunisia","volume":"11","author":"Soltani","year":"2005","journal-title":"La Revue de Sant\u00e9 de la M\u00e9diterran\u00e9e orientale"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0145","first-page":"118","article-title":"Preliminary assessment of Streptococcus pneumoniae, pneumonia, economical and clinical burden in Romania","volume":"56","author":"Stoicescu","year":"2007","journal-title":"Pneumologia (Bucharest, Romania)"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/02724939992301","article-title":"Response to antimicrobial therapy in childhood bacterial meningitis in tropical Africa: report of a bi-centre experience in Nigeria, 1993\u20131998","volume":"19","author":"Akpede","year":"1999","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0155","first-page":"455","article-title":"The use of a modified out-patient infusion therapy for lowering the cost in suleimania child's hospital","volume":"28","author":"Al-Howasi","year":"1996","journal-title":"J Kuwait Med Assoc"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0160","first-page":"257","article-title":"Packaged treatment for first-line care in cerebral malaria and meningitis","volume":"76","author":"Cullinan","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0165","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.vaccine.2009.12.070","article-title":"Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina","volume":"28","author":"Giglio","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bmj.3.5876.379","article-title":"Trial of chloramphenicol for meningitis in northern savanna of Africa","volume":"3","author":"Whittle","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00271911","article-title":"Cost effectiveness calculations for the diagnosis and treatment of tuberculous meningitis","volume":"5","author":"McNeil","year":"1980","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or =100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0185","first-page":"376","article-title":"Incorporation of private demand into cost-benefit analysis of a universal Hib vaccination program in Thailand","volume":"42","author":"Muangchana","year":"2011","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/heapol\/czs075","article-title":"Forecasting burden of long-term disability from neonatal conditions: results from the Projahnmo I trial, Sylhet, Bangladesh","volume":"28","author":"Shillcutt","year":"2013","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)60195-0","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis","volume":"369","author":"Sinha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0200","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2010.12.122","article-title":"Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda","volume":"29","author":"Tate","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0205","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.vaccine.2011.04.111","article-title":"Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina","volume":"29","author":"Uruena","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0210","first-page":"395","article-title":"Contribution to the study of cerebro-spinal meningitis in Niger","volume":"21","author":"Wone","year":"1976","journal-title":"Bulletin de la Societe Medicale d\u2019Afrique Noire de Langue Francaise"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0215","first-page":"S53","article-title":"Implication of pneumococcal conjugate vaccines to public health: Thailand perspective","volume":"93","author":"Wongsawat","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4314\/pamj.v4i1.53613","article-title":"Chronic suppurative otitis media: socio-economic implications in a tertiary hospital in Northern Nigeria","volume":"4","author":"Adoga","year":"2010","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/heapol\/czn033","article-title":"Economic analysis of childhood pneumonia in Northern Pakistan","volume":"23","author":"Hussain","year":"2008","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0230","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1016\/j.ijid.2010.02.2262","article-title":"Clinical and economic burden of pneumonia among adults in Latin America","volume":"14","author":"Isturiz","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0235","first-page":"215","article-title":"Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997","volume":"13","author":"Da Silva","year":"2003","journal-title":"Cahiers Sante"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0240","first-page":"58","article-title":"Post-marketing study to assess the safety, tolerability and effectiveness of Fungisome(trademark): An Indian liposomal amphotericin B preparation","volume":"51","author":"Hegde","year":"2005","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0245","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00006454-199912000-00005","article-title":"Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa","volume":"18","author":"Miller","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00019053-200119010-00001","article-title":"Enteroviral meningitis: cost of illness and considerations for the economic evaluation of potential therapies","volume":"19","author":"Parasuraman","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0255","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/S0264-410X(01)00066-4","article-title":"Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis","volume":"19","author":"Parent du Chatelet","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18553\/jmcp.2010.16.1.32","article-title":"Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea","volume":"16","author":"Sohn","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/14992020802538081","article-title":"Cost-effectiveness of selected interventions for hearing impairment in Africa and Asia: a mathematical modelling approach","volume":"48","author":"Baltussen","year":"2009","journal-title":"Int J Audiol"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0270","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1136\/bmj.e615","article-title":"Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study","volume":"344","author":"Baltussen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0275","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0277-9536(98)00419-5","article-title":"A cost-effectiveness analysis of vaccination strategies against N. meningitidis meningitis in sub-Saharan African countries","volume":"48","author":"Bovier","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/pubmed\/fdm055","article-title":"Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis","volume":"29","author":"Broughton","year":"2007","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0285","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1016\/j.vaccine.2011.08.006","article-title":"Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population","volume":"29","author":"Castaneda-Orjuela","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0290","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.vaccine.2012.01.031","article-title":"Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children","volume":"30","author":"Castaneda-Orjuela","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0295","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jval.2011.05.045","article-title":"Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil","volume":"14","author":"de Soarez","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0300","first-page":"213","article-title":"Haemophilus influenzae type b meningitis: how much better is prevention than cure?","volume":"45","author":"Duke","year":"2002","journal-title":"P N G Med J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0305","series-title":"Cost effectiveness of immunization against Haemophilus influenzae type b in children aged 0\u20134","first-page":"31","author":"Garcia Fari\u00f1as","year":"2005"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.11.061_bib0310","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.1016\/j.vaccine.2011.06.095","article-title":"The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America","volume":"29","author":"Giglio","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/heapol\/czs025","article-title":"Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India","volume":"28","author":"Gupta","year":"2013","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0320","first-page":"20","article-title":"The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease","volume":"85","author":"Hussey","year":"1995","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0325","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0330","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/00006454-199809001-00010","article-title":"The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries","volume":"17","author":"Lagos","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00019053-200119040-00006","article-title":"Cost-benefit analysis of a Haemophilus influenzae type B meningitis prevention programme in the Philippines","volume":"19","author":"Limcangco","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0340","first-page":"332","article-title":"Immunization against Haemophilus influenzae type B in Iran; cost-utility and cost-benefit analyses","volume":"3","author":"Moradi-Lakeh","year":"2005","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0345","first-page":"173","article-title":"Cost-benefit analysis of a regional system for vaccination against pneumonia, meningitis type B, and typhoid fever","volume":"26","author":"Musgrove","year":"1992","journal-title":"Bull Pan Am Health Organ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0350","doi-asserted-by":"crossref","first-page":"e13044","DOI":"10.1371\/journal.pone.0013044","article-title":"Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso","volume":"5","author":"Somda","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0355","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1377\/hlthaff.2011.0382","article-title":"Estimated economic benefits during the \u2018decade of vaccines\u2019 include treatment savings, gains in labor productivity","volume":"30","author":"Stack","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0360","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ije\/dyh341","article-title":"An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting","volume":"34","author":"Mangtani","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 6","key":"10.1016\/j.vaccine.2014.11.061_bib0365","doi-asserted-by":"crossref","first-page":"G23","DOI":"10.1016\/j.vaccine.2010.06.016","article-title":"Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries","volume":"28","author":"Talbird","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0370","first-page":"447","article-title":"Treatment of patients with bacterial infections of the central nervous system\u2014a pharmaco-economical analysis","volume":"142","author":"Dimitrov","year":"2003","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0375","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2334-10-260","article-title":"Economic evaluation of pneumococcal conjugate vaccination in The Gambia","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0380","series-title":"Note on the methodology used to predict unit costs for patient services. WHO-CHOICE 2011","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0385","series-title":"Bootstrap methods: a guide for practitioners and researchers","author":"Chernick","year":"2007"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0390","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hec.683","article-title":"Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods","volume":"11","author":"Graves","year":"2002","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0395","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1590\/S1020-49892009000500007","article-title":"Childhood pneumococcal disease burden in Argentina","volume":"25","author":"Augustovski","year":"2009","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0400","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.vaccine.2011.05.058","article-title":"Costs and impact of meningitis epidemics for the public health system in Burkina Faso","volume":"29","author":"Colombini","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0405","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/644623","article-title":"Costs for households and community perception of meningitis epidemics in Burkina Faso","volume":"49","author":"Colombini","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0410","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/INF.0b013e3182615297","article-title":"Costs of meningitis sequelae in children in Dakar","volume":"31","author":"Griffiths","year":"2012","journal-title":"Senegal Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0415","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hpm.847","article-title":"The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan","volume":"21","author":"Hussain","year":"2006","journal-title":"Int J Health Plann Manage"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.11.061_bib0420","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1111\/j.1524-4733.2009.00626.x","article-title":"Economic evaluation of universal infant vaccination with 7vPCV in Hong Kong","volume":"12","author":"Lee","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0425","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S1020-49892008001100002","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis","volume":"24","author":"Sinha","year":"2008","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Health"},{"issue":"Suppl. 6","key":"10.1016\/j.vaccine.2014.11.061_bib0430","doi-asserted-by":"crossref","first-page":"G14","DOI":"10.1016\/j.vaccine.2010.06.080","article-title":"Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae-associated disease following vaccination with PCV-7: a multicountry analysis","volume":"28","author":"Talbird","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0435","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-3156.2003.01189.x","article-title":"Strengthening health services to control epidemics: empirical evidence from Guinea on its cost-effectiveness","volume":"9","author":"Van Damme","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0440","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2471\/BLT.06.034686","article-title":"Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization sevices in Kenya","volume":"85","author":"Akumu","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0445","first-page":"139","article-title":"Pediatric treatment costs and the HIV epidemic","volume":"41","author":"Nelson","year":"1995","journal-title":"Cent Afr J Med"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0450","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/INF.0b013e318165f1ba","article-title":"Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia","volume":"27","author":"Gessner","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0455","first-page":"135","article-title":"Priority during a meningitis epidemic: vaccination or treatment?","volume":"76","author":"Veeken","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0460","first-page":"436","article-title":"Treatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Nam","volume":"28","author":"Anh","year":"2010","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0465","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/oxfordjournals.aje.a116624","article-title":"Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile","volume":"137","author":"Levine","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0470","first-page":"580","article-title":"Viral infections, prevalence and costs: a 5-year, hospital based, retrospective observational study in Shiraz, Iran","volume":"23","author":"Sabayan","year":"2007","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0475","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.vaccine.2005.11.054","article-title":"Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation","volume":"24","author":"Platonov","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0480","first-page":"58","article-title":"Human immunodeficiency virus (HIV) related cryptococcal meningitis in rural central Thailand","volume":"38","author":"Wright","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0485","doi-asserted-by":"crossref","first-page":"e21472","DOI":"10.1371\/journal.pone.0021472","article-title":"Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan","volume":"6","author":"Griffiths","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.11.061_bib0490","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/S1020-49892007000900007","article-title":"Evaluating the costs of pneumococcal disease in selected Latin American countries","volume":"22","author":"Constenla","year":"2007","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T02:42:05Z","timestamp":1598928125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14016454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":98,"alternative-id":["S0264410X14016454"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating costs of care for meningitis infections in low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}